000 01512 a2200457 4500
005 20250517045815.0
264 0 _c20161031
008 201610s 0 0 eng d
022 _a1476-5462
024 7 _a10.1038/gt.2015.91
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYamamoto, H
245 0 0 _aBTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector.
_h[electronic resource]
260 _bGene therapy
_cFeb 2016
300 _a205-13 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAgammaglobulinaemia Tyrosine Kinase
650 0 4 _aAgammaglobulinemia
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aDependovirus
_xgenetics
650 0 4 _aGene Targeting
650 0 4 _aGenetic Diseases, X-Linked
_xgenetics
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
_xgenetics
650 0 4 _aHelper Viruses
_xgenetics
650 0 4 _aHomologous Recombination
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMutation
650 0 4 _aProtein-Tyrosine Kinases
_xgenetics
700 1 _aIshimura, M
700 1 _aOchiai, M
700 1 _aTakada, H
700 1 _aKusuhara, K
700 1 _aNakatsu, Y
700 1 _aTsuzuki, T
700 1 _aMitani, K
700 1 _aHara, T
773 0 _tGene therapy
_gvol. 23
_gno. 2
_gp. 205-13
856 4 0 _uhttps://doi.org/10.1038/gt.2015.91
_zAvailable from publisher's website
999 _c25175789
_d25175789